Human antibody response to dengue virus : implications for dengue vaccine design

• Material Type: 記事
• Title: Human antibody response to dengue virus : implications for dengue vaccine design
• Author/Editor: Meng Ling Moi; Tomohiko Takasaki; Ichiro Kurane
• Publication, Distribution, etc.: 日本 : Springer Nature
• Publication Date: 2016-03-14
• Publication Date (W3CDTF): 2016-03-14
• Periodical title: Tropical medicine and health
• No. or year of volume/issue: 44(1)
• Volume: 44(1)
• ISSN (Periodical Title): 1349-4147
• ISSN-L (Periodical Title): 1348-8945
• Text Language Code: eng
• DOI: 10.1186/s41182-016-0004-y; https://doi.org/10.1186/s41182-016-0004-y
• Persistent ID (NDL): info:ndljp/pid/10233086; https://dl.ndl.go.jp/pid/10233086
• Collection: 障害者向け資料
• Collection (Materials For Handicapped People:1): テキストデータ
• Collection (particular): 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他; https://dl.ndl.go.jp/collections/B00035
• Acquisition Basis: オンライン資料収集制度
• Date Accepted (W3CDTF): 2016-12-28T13:40:57+09:00
• Date Captured (W3CDTF): 2016-12-26
• Format (IMT): application/pdf
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象外
• Availability of remote photoduplication service: 可
• Periodical Title (URI): http://tropmedhealth.biomedcentral.com/articles?searchType=journalSearch&sort=PubDate&page=2
• Periodical Title (Persistent ID (NDL)): info:ndljp/pid/10233085; https://dl.ndl.go.jp/pid/10233085
• Data Provider (Database): 国立国会図書館 : 国立国会図書館デジタルコレクション; https://dl.ndl.go.jp

• Collection (particular): 国立国会図書館デジタルコレクション > デジタル化資料 > 雑誌; https://dl.ndl.go.jp/collections/A00002
• Access Restrictions: 国立国会図書館内限定公開
• Service for the Digitized Contents Transmission Service: 図書館・個人送信対象
• Availability of remote photoduplication service: 可
• Holding library: 国立国会図書館
• Call No.: Z1-286
• Periodical Title (Persistent ID (NDL)): info:ndljp/pid/12118332; https://dl.ndl.go.jp/pid/12118332
• Data Provider (Database): 国立国会図書館 : 国立国会図書館雑誌記事索引; https://ndlsearch.ndl.go.jp
• Bibliographic ID (NDL): 10233086; http://id.ndl.go.jp/bib/10233086
• Bibliographic Record Category (NDL): 632

• Summary, etc.: Dengue, a global health threat, is a leading cause of morbidity and mortality in most tropical and subtropical countries. Dengue can range from asymptomatic, relatively mild dengue fever to severe and life-threatening dengue hemorrhagic fever. Disease severity and outcome is largely associated with the host immune response. Several candidate vaccines in clinical trials appear promising as effective measures for dengue disease control. Vaccine development has been hampered by safety and efficacy issues, driven by a lack of understanding of the host immune response. This review focuses on recent research findings on the dengue host immune response, particularly in humans, and the relevance of these findings to challenges in vaccine development.; Tropical Medicine and Health, 44, 1; 2016
• DOI: 10.1186/s41182-016-0004-y; https://doi.org/10.1186/s41182-016-0004-y
• Access Restrictions: インターネット公開
• Rights (production): c Moi et al 2016; This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
• Related Material (URI): http://hdl.handle.net/10069/37291; https://nagasaki-u.repo.nii.ac.jp/records/2096; http://id.ndl.go.jp/digimeta/10233086; https://dl.ndl.go.jp/pid/10233086; http://link.springer.com/content/pdf/10.1186/s41182-016-0004-y; https://search.jamas.or.jp/link/ui/2018007014
• References: Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans; https://cir.nii.ac.jp/crid/1360004234933195008; Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial; https://cir.nii.ac.jp/crid/1360011144763856000; Serological evidence for the co-circulation of multiple dengue virus serotypes in Singapore; https://cir.nii.ac.jp/crid/1360011145423253120; Detection of Higher Levels of Dengue Viremia Using FcγR-Expressing BHK-21 Cells Than FcγR-Negative Cells in Secondary Infection but Not in Primary Infection; https://cir.nii.ac.jp/crid/1360283692546421760; Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing FcγRIIA; https://cir.nii.ac.jp/crid/1360292618724069248; Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections; https://cir.nii.ac.jp/crid/1360292620163027200; Impaired T Cell Proliferation in Acute Dengue Infection; https://cir.nii.ac.jp/crid/1360298345420694784; Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection; https://cir.nii.ac.jp/crid/1360567184719785472; RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND; https://cir.nii.ac.jp/crid/1360574093725398528; Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.; https://cir.nii.ac.jp/crid/1360579820396989184; Comparison of Plaque- and Enzyme-Linked Immunospot-Based Assays To Measure the Neutralizing Activities of Monoclonal Antibodies Specific to Domain III of Dengue Virus Envelope Protein; https://cir.nii.ac.jp/crid/1360855569184969216; Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes; https://cir.nii.ac.jp/crid/1360855569399784064; Autochthonous Dengue Fever, Tokyo, Japan, 2014; https://cir.nii.ac.jp/crid/1360855569841022592; Characteristic of Dengue Disease in Taiwan: 2002–2007; https://cir.nii.ac.jp/crid/1360855570724548736; Autochthonous dengue fever in Croatia, August–September 2010; https://cir.nii.ac.jp/crid/1360861294709302784; The global distribution and burden of dengue; https://cir.nii.ac.jp/crid/1361137044225776768; Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection; https://cir.nii.ac.jp/crid/1361137045521351040; Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera; https://cir.nii.ac.jp/crid/1361137046470464128; Antibody Responses to Asian and American Genotypes of Dengue 2 Virus in Immunized Mice; https://cir.nii.ac.jp/crid/1361418518806380928; Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine; https://cir.nii.ac.jp/crid/1361418519563649664; A simple assay system for infection-enhancing and -neutralizing antibodies to dengue type 2 virus using layers of semi-adherent K562 cells; https://cir.nii.ac.jp/crid/1361699993546948736; High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection; https://cir.nii.ac.jp/crid/1361699995957507712; Autochthonous case of dengue in France, October 2013; https://cir.nii.ac.jp/crid/1361699996071449856; Discrepancy in Dengue Virus Neutralizing Antibody Titers between Plaque Reduction Neutralizing Tests with Fcγ Receptor (FcγR)-Negative and FcγR-Expressing BHK-21 Cells; https://cir.nii.ac.jp/crid/1361981470205433856; Spatial and Temporal Circulation of Dengue Virus Serotypes: A Prospective Study of Primary School Children in Kamphaeng Phet, Thailand; https://cir.nii.ac.jp/crid/1362262943760125824; Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial; https://cir.nii.ac.jp/crid/1362262944636096384; Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever; https://cir.nii.ac.jp/crid/1362262945498153856; Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity; https://cir.nii.ac.jp/crid/1362544418986567424; Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease; https://cir.nii.ac.jp/crid/1362544419728775296; Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants; https://cir.nii.ac.jp/crid/1362544420147928064; Research on Dengue during World War II; https://cir.nii.ac.jp/crid/1362825894348294400; Dengue Virus (DV) Enhancing Antibody Activity in Preillness Plasma Does Not Predict Subsequent Disease Severity or Viremia in Secondary DV Infection; https://cir.nii.ac.jp/crid/1362825894451802368; Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America; https://cir.nii.ac.jp/crid/1362825896037327488; Differing Influences of Virus Burden and Immune Activation on Disease Severity in Secondary Dengue‐3 Virus Infections; https://cir.nii.ac.jp/crid/1363107368929247616; Relationship of Preexisting Dengue Virus (DV) Neutralizing Antibody Levels to Viremia and Severity of Disease in a Prospective Cohort Study of DV Infection in Thailand; https://cir.nii.ac.jp/crid/1363388844184698112; A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.; https://cir.nii.ac.jp/crid/1363670320226169984; The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity; https://cir.nii.ac.jp/crid/1363670320662319104; Difference between the Abilities of Human Fcγ Receptor-Expressing CV-1 Cells To Neutralize American and Asian Genotypes of Dengue Virus 2; https://cir.nii.ac.jp/crid/1364233269994485888; Antibody-Dependent Enhancement of Dengue Virus Growth in Human Monocytes as a Risk Factor for Dengue Hemorrhagic Fever; https://cir.nii.ac.jp/crid/1364233270908883712; T-cell Responses to Dengue Virus in Humans; https://cir.nii.ac.jp/crid/1390001205219256832
• Data Provider (Database): 国立情報学研究所 : CiNii Research; https://cir.nii.ac.jp/
• Original Data Provider (Database): 学術機関リポジトリデータベース; https://irdb.nii.ac.jp; 雑誌記事索引データベース; https://ndlsearch.ndl.go.jp; Crossref; https://www.crossref.org; CiNii Articles; 科学研究費助成事業データベース; https://kaken.nii.ac.jp/ja
• Bibliographic ID (NDL): 10233086; http://id.ndl.go.jp/bib/10233086
• NAID: 120006987654